PYPDPolyPidPYPD info
$3.45info-0.29%24h
Global rank34223
Market cap$5.70M
Change 7d-1.71%
YTD Performance-15.85%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    PolyPid (PYPD) Stock Overview

    PolyPid Ltd., a clinical-stage pharmaceutical company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which helps in the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

    PYPD Stock Information

    Symbol
    PYPD
    Address
    18 Hasivim StreetPetah Tikva, 4959376Israel
    Founded
    -
    Trading hours
    -
    Website
    https://www.polypid.com
    Country
    🇮🇱 Israel
    Phone Number
    972 7 4719 5700

    PolyPid (PYPD) Price Chart

    -
    Value:-

    PolyPid Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.45
    N/A
    Market Cap
    $5.70M
    N/A
    Shares Outstanding
    1.65M
    N/A
    Employees
    57.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org